Molecular Targeting Collaborates with Taiwan’s National Health Research Institutes
August 07, 2014 at 06:59 AM EDT
Molecular Targeting Technologies, Inc. (MTTI) of Pennsylvania has formed a collaboration with the National Health Research Institutes of Taiwan to develop novel cancer drugs using a delivery technology in-licensed by MTTI. The collaboration has completed proof-of-concept studies in mouse models of colon cancer and will now begin work on identifying lead molecules of a small molecule drug conjugate. Details of the collaboration were not disclosed. More details.... Share this with colleagues: // //